Endometrial Cancer Screening in High-risk Populations

NANot yet recruitingINTERVENTIONAL
Enrollment

22,000

Participants

Timeline

Start Date

November 15, 2023

Primary Completion Date

December 30, 2024

Study Completion Date

December 30, 2025

Conditions
Cancer Screening
Interventions
DIAGNOSTIC_TEST

transvaginal ultrasound and microscale endometrial sampling biopsy

Transvaginal ultrasound and endometrial micro tissue pathology examination are used concurrently for endometrial cancer screening in high-risk populations. The specificity, sensitivity, and optimal combination of the two screening methods are clarified, and a cost-effectiveness analysis is conducted on different screening strategy.

All Listed Sponsors
lead

Peking University People's Hospital

OTHER

NCT06125886 - Endometrial Cancer Screening in High-risk Populations | Biotech Hunter | Biotech Hunter